Abstract
In the CNS, endocannabinoids are identified mainly as two endogenous lipids: anandamide, the ethanolamide of arachidonic acid, and 2-arachidonoylglycerol (2-AG). Endocannabinoids are known to inhibit transmitter release from presynaptic terminals; however we have recently demonstrated that they are also involved in slow self-inhibition (SSI) of layer V low-threshold spiking (LTS) interneurons in rat somatosensory cortex. SSI is induced by repetitive firing in LTS cells, which can express either cholecystokinin or somatostatin. SSI is triggered by an endocannabinoid-dependent activation of a prolonged somatodendritic K+ conductance and associated hyperpolarization in the same cell. The synthesis of both endocannabinoids is dependent on elevated [Ca2+]i such as occurs during sustained neuronal activity. To establish whether 2-AG mediates autocrine LTS-SSI, we blocked its biosynthesis from phospholipase C (PLC) and diacylglycerol lipases (DAGLs). Current-clamp recordings from LTS interneurons in acute neocortical slices showed that inclusion of DAGL inhibitors in the whole-cell pipette prevented the long-lasting hyperpolarization triggered by LTS cell repetitive firing. Similarly, extracellular applications of a PLC inhibitor prevented SSI in LTS interneurons. Moreover, metabotropic glutamate receptor-dependent activation of PLC produced a long-lasting hyperpolarization which was prevented by the CB1 antagonist AM251, as well as by PLC and DAGL inhibitors. The loss of SSI in the presence of intracellular DAGL blockers confirms that endocannabinoid production occurs in the same interneuron undergoing the persistent hyperpolarization. Since DAGLs produce no endocannabinoid other than 2-AG, these results identify this compound as the autocrine mediator responsible for the postsynaptic slow self-inhibition of neocortical LTS interneurons.
Introduction
Endocannabinoids are the endogenous ligands of the cannabinoid receptor CB1 and CB2. These receptors are the target of Δ9-tetrahydrocannabinol, the active principle of the recreational drug marijuana, well known for its psychoactive and analgesic effects (Freund et al., 2003; Iversen, 2003). Activation of the cannabinoid system typically leads to disruption of psychomotor behavior, short-term memory impairment, intoxication, and stimulation of appetite (Iversen, 2003; Di Marzo and Matias, 2005). At the cellular level, activation of CB1 receptors activates potassium channels (Deadwyler et al., 1995; Mackie et al., 1995) and inhibits calcium channel function (Mackie and Hille, 1992; Kreitzer and Regehr, 2001). Since CB1 receptors are highly expressed in presynaptic terminals, CB1-mediated effects on calcium channels can result in a reduced release of either GABA or glutamate (Hájos et al., 2000; Kreitzer and Regehr, 2001; Ohno-Shosaku et al., 2001; Wilson et al., 2001; Freund et al., 2003).
We have recently found that, in layer V of rat neocortex, a subtype of GABAergic interneurons, classified as low-threshold spiking (LTS), undergoes a prominent and long-lasting hyperpolarization following their own repetitive firing. This slow self-inhibition (SSI) is due to the postsynaptic activation of a G-protein-coupled inward rectifier potassium (GIRK) conductance triggered by an activity-dependent autocrine action of endocannabinoids (Bacci et al., 2004).
Endogenous cannabinoids are identified mainly in two endogenous lipids: the ethanolamide of arachidonic acid, anandamide (Devane et al., 1992; Mechoulam et al., 1994), and 2-arachidonoylglycerol (2-AG) (Mechoulam et al., 1995; Sugiura et al., 1995). The “on demand” biosynthesis of anandamide and 2-AG is strongly dependent on rises of intracellular Ca2+ concentration (Di Marzo et al., 1994; Cadas et al., 1996; Bisogno et al., 1997; Cadas et al., 1997; Sasaki and Chang, 1997; Stella et al., 1997; Stella and Piomelli, 2001), such as occur during sustained neuronal activity. Anandamide and 2-AG are synthesized through different biochemical pathways, both using phospholipids as precursors. Anandamide is synthesized via hydrolysis of the phospholipid precursor N-arachidonoyl phosphatidylethanolamine via potentially alternative pathways (Di Marzo et al., 1994; Sugiura et al., 1996a,b; Liu et al., 2008; Simon and Cravatt, 2008). Two possible pathways involving phospholipase C (PLC), or phosphatidic acid hydrolase are believed to lead to the synthesis of 2-AG (Freund et al., 2003; Piomelli, 2003; Di Marzo et al., 2005). Diacylglycerols (DAGs), a major source of 2-AG for these pathways, are always converted into the endocannabinoid by diacylglycerol lipases (DAGLs) (Bisogno et al., 1997, 1999; Stella et al., 1997), and are in turn produced via either PLC-dependent or -independent pathways. The last step of 2-AG biosynthesis is catalyzed by a specific enzyme, sn-1-DAG lipase, which is present in two isoforms in neurons (DAGLα and DAGLβ). The expression of sn-1-DAG lipase-α in postsynaptic cells of adult rodents is correlated with 2-AG biosynthesis (Bisogno et al., 2003; Yoshida et al., 2006). DAGL substrates can be produced by PLCβ, which cleaves membrane phosphatidylinositol 4,5-bisphosphate (PIP2) into IP3 and DAG (Freund et al., 2003; Piomelli, 2003; Bisogno et al., 2005). In neurons, PLCβ can be activated by group I metabotropic glutamate receptors (mGluRs). Indeed, endocannabinoid-dependent modulation of both short- and long-term synaptic transmission relies on mGluR activation in several brain areas (Varma et al., 2001; Brown et al., 2003; Freund et al., 2003; Piomelli, 2003; Jung et al., 2005; Maejima et al., 2005; Chevaleyre et al., 2006; Jung et al., 2007). Although the active players in the synthetic pathways of both anandamide and 2-AG are known, specific pharmacological agents that can be used to block the biosynthesis of endocannabinoids are lacking. Recently, specific inhibitors for the DAGL have been synthesized (Bisogno et al., 2006). Here we show that SSI can be robustly induced in LTS interneurons that express the neuropeptide somatostatin (SST), extending our previous findings demonstrating SSI expression in CCK-containing LTS cells. Blocking the last step in 2-AG production prevented SSI. Moreover, PLC blockade prevented SSI, whereas PLC activation by a mGluR agonist mimicked SSI in LTS interneurons. Together these results identify 2-AG as the endogenous cannabinoid responsible for the induction of this phenomenon.
Materials and Methods
In vitro slice preparation and electrophysiology.
Sprague Dawley rats aged postnatal day 13 (P13)–P21 were deeply anesthetized with pentobarbital (50 mg/kg) and decapitated, and their brains were removed and immersed in cold “cutting” solution (4°C) containing (in mm): 234 sucrose, 11 glucose, 24 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 10 MgSO4, and 0.5 CaCl2, gassed with 95% O2/5% CO2. Coronal slices (300 μm) were cut from somatosensory cortex (parietal area 1) with a vibratome and then incubated in oxygenated artificial CSF (ACSF) containing (in mm): 126 NaCl, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2 MgSO4, 2 CaCl2, and 10 glucose; pH 7.4, initially at 32°C for 1 h, and subsequently at room temperature, before being transferred to the recording chamber and maintained at 32°C. Recordings were obtained from visually identified interneurons in layer V, easily distinguished from pyramidal neurons by the lack of a large emerging apical dendrite. LTS cells were identified by previously described electrophysiological properties (Bacci et al., 2003b, 2004).
Experiments were performed in the whole-cell configuration of the patch-clamp technique. Electrodes (tip resistance = 2–3 MΩ, and 5–7 MΩ for experiments involving biocytin fills) were filled with an intracellular solution containing (in mm): 70 K-gluconate, 70 KCl, 2 NaCl, 10 HEPES, 10 EGTA, 2 MgCl2; pH adjusted to 7.3 with KOH; 290 mOsm. In some experiments K-gluconate and KCl were 130 and 10 mm respectively. Drugs were delivered using a local perfusion system composed of multiple fine tubes ending in a common outlet tube, positioned in proximity (∼250 μm) to the recorded neuron. Experiments were performed in the presence of the ionotropic glutamate receptor blockers 6,7-dinitroquinoxaline-2,3,dione (DNQX, 10 μm) and dl-2-amino-5-phosphonovaleric acid (dl-APV, 100 μm) in the bath and local perfusate. In some experiments the GABAA receptor blocker gabazine (10 μm) was included in the perfusate. Tetrahydrolipstatin (THL) was obtained from the Di Marzo laboratory, whereas O-3841 was a kind gift from Raj Razdan's laboratory (Organix). AM-251, CHPG, U73122, tetrodotoxin, DNQX, gabazine, and dl-APV were from Tocris Bioscience. U-73343 was from Sigma.
Signals were amplified using a Multiclamp 700B patch-clamp amplifier (Molecular Devices), sampled at 20 kHz, and filtered at 10 kHz, unless otherwise noted. A Digidata 1320 digitizer and PClamp9 (Molecular Devices) were used for data acquisition and analysis. Membrane conductance was measured from responses to small current injections (−15 to −30 pA, 250 ms, 0.2 Hz). SSI-inducing stimuli consisted of 10 trains of either 10 or 50 Hz APs (60 APs/train), evoked every 20 s. Results are presented as means ± SEM. Unless otherwise noted, paired Student's t test was used to compare control data with those obtained in the same neurons after drug applications or 5–8 min following SSI-inducing stimuli. Differences were considered significant if p < 0.05.
Immunocytochemistry.
Biocytin (0.1–0.05%, Sigma) was included in the internal solution to fill neurons during electrophysiological recordings. Slices were subsequently fixed overnight in 4% paraformaldehyde in phosphate buffer (PB, pH 7.4) at 4°C, cryoprotected in 30% sucrose in 0.1 m phosphate buffer and sectioned (40 μm thickness) with a cryostat (Leica). Sections were blocked in PB + BSA 10%+ Triton X-100 0.3% for 2 h, and incubated overnight with anti-CCK (5 mg/ml diluted 1:1000 in PB + 0.3% Triton X-100 and 0.1% normal donkey serum) antibody. For CCK immunostaining we used a monoclonal antibody raised against CCK/Gastrin (No. 28.2 MoAb) that was kindly provided by Dr G. Ohning at the CURE/Digestive Diseases Research Center, Antibody/RIA Core, University of California, Los Angeles. Sections were rinsed twice in PB and incubated for 3.5 h in secondary antibodies (donkey anti mouse-Cy2 1:100, Molecular Probes), diluted in PB + 0.3% Triton X-100 and 0.1% normal donkey serum. Sections were rinsed in PB and incubated 1 h in Cy3-conjugated streptavidin (Jackson ImmunoResearch, diluted 1:250). For SST-immunostaining, slices were incubated with an anti-SST antibody (1:250; rabbit anti somatostatin T-4103, Peninsula Laboratories) overnight at 4°C with 0.3% Triton X-100 and 0.1% normal donkey serum in PB. Slices were rinsed in PB and incubated 3.5 h in PB with 0.3% Triton X-100, secondary Cy2-conjugated anti-rabbit antibody (1:100, Jackson ImmunoResearch), and Cy3-conjugated streptavidin (1:250, Jackson ImmunoResearch). Fluorescent biocytin-filled neurons and CCK or SST immunoreactivity were then observed with a laser confocal microscope (Leica SP5) and images were acquired.
Results
Somatostatin-positive LTS interneurons express CB1-mediated SSI
We obtained whole-cell recordings from interneurons in rat neocortical slices. Interneurons were identified morphologically using infrared videomicroscopy as cells with round bipolar or multipolar cell bodies, lacking a clear apical dendrite. Firing behavior in current clamp was characterized in response to square DC current injections, as previously published (Bacci et al., 2003a,b, 2004). In layer V, we found two major neuronal subtypes that could be characterized as GABAergic interneurons by their firing behaviors: (1) cells that responded to depolarizing steps with abrupt fast spiking (FS), with little or no adaptation and the absence of a rebound burst following a hyperpolarizing step [these interneurons are typically morphologically identified as basket or chandelier cells (Kawaguchi and Kubota, 1997, 1998)]; (2) low-threshold spiking (LTS) cells, which generated an action potential or a rebound burst of spikes riding on a depolarizing hump following a hyperpolarizing current injection (Fig. 1C,G) and a relatively adapting firing behavior in response to depolarizing steps (Bacci et al., 2003a,b, 2004). Although LTS cells might include several morphologically identified interneuron subtypes (Kawaguchi and Kubota, 1997, 1998), we previously found that neocortical layer V LTS cells we recorded consistently expressed the neuropeptide CCK (Bacci et al., 2004), which is known to be coexpressed with CB1 receptors in the neocortex and hippocampus (Katona et al., 1999; Marsicano and Lutz, 1999; Freund et al., 2003; Bodor et al., 2005). However, the vast majority of deep-layer cortical LTS interneurons are known to express the neuropeptide somatostatin (SST) (Cauli et al., 1997; Kawaguchi and Kondo, 2002; Goldberg et al., 2004; Ma et al., 2006) and little or no overlap between CCK- and SST-containing interneurons has been shown (Kawaguchi and Kondo, 2002; Uematsu et al., 2008). Interestingly, CB1 mRNA expression has been detected in a vast majority of SST- and calbindin D28K-positive cells (>60%; Hill et al., 2007), in line with previous evidence showing CB1 mRNA expression in a significant percentage of calbindin D28K-positive interneurons (Marsicano and Lutz, 1999). Notably, calbindin D28K-positive cortical interneurons frequently coexpress somatostatin (Kawaguchi and Kubota, 1997; Hill et al., 2007). In the present study we extended our previous preliminary immunohistochemical results (Bacci et al., 2004) and tested whether SST-expressing LTS interneurons could generate slow self-inhibition (SSI). We filled neurons with biocytin and counter-stained them with antibodies against SST or CCK (n = 56) (Fig. 1B,F; supplemental Fig. 2, available at www.jneurosci.org as supplemental material). We found that LTS interneurons can express either SST (n = 36) (Fig. 1B,F) or CCK (n = 8) (supplemental Fig. 2, available at www.jneurosci.org as supplemental material). In these experiments, we might have underestimated the total number of SST- or CCK-positive cells, as immunoreactivity was lost in many experiments, likely due to the dialysis of LTS neuron cytoplasm by whole-cell pipettes. This was indicated by the appearance of biocytin-positive neurons devoid of reaction product (n = 21, data not shown), and by a higher incidence of immunopositive neurons when whole-cell recordings lasted <1 min. However, we cannot exclude the possibility that neurons lacking expression of SST and CCK represent another subtype of LTS cells. In a previous publication, we reported that 7 LTS cells filled with biocytin contained CCK (Bacci et al., 2004), whereas in the current results 36 of 56 of LTS cells were SST positive and only 8 of 56 contained CCK. We have no explanation for this difference, although the relatively small number of immunoreacted cells in the earlier experiments may have provided an inadequate sample.
When LTS interneurons were stimulated by directly evoking 10 trains of 60 action potentials at either 10 or 50 Hz, 78% (n = 47) responded to these cycles of activity with a prominent and long-lasting hyperpolarization (Figs. 1D, 2A, 3A), as previously described (Bacci et al., 2004). SSI was associated with an increase in membrane conductance measured as a reduced response to a hyperpolarizing current injection delivered every 5–20 s throughout the experiment (Figs. 1D,H, 2B, 3B). Membrane conductance was not different when the Vm was reset to baseline levels with DC current injection during the slow SSI-induced hyperpolarization (2.64 ± 0.4 nS vs 2.16 ± 0.6, post-SSI gm vs post-SSI gm with DC current injection; p > 0.2; pre-SSI gm = 1.42 ± 0.2, p < 0.05 when compared with post-SSI and post-SSI with DC current injection; n = 3; data not shown). Some of these LTS interneurons were filled with biocytin (n = 32). SSI could be induced in 1 out of 1 CCK-positive cell (data not shown), in 16 out of 23 SST-positive interneurons (Fig. 1D) (ΔVm = −6.0 ± 0.65 mV after SSI-inducing AP trains p < 0.001), and in 4 out of 7 cells which were negative to both CCK and SST (data not shown). We have previously demonstrated that SSI is due to a persistent CB1 receptor-dependent activation of a GIRK conductance (Bacci et al., 2004). Accordingly, in 3 out of 5 SST+ LTS cells, application of CB1R antagonist AM-251 (3 μm) terminated the SSI-induced hyperpolarization (Fig. 1H) (ΔVm = −2.66 ± 2.18 mV 10 min after AM-251 application; p > 0.05). These results indicate that SST+ interneurons express a CB1-mediated SSI similar to CCK-containing cells.
We found that an activity-dependent long-lasting hyperpolarization in LTS interneurons required at least 100 spikes at 10 Hz (p < 0.01, n = 5) and the amplitude of the hyperpolarization was progressively increased through further prolongation of the spike train (data not shown).
Intracellular blockade of DAGL prevents SSI in neocortical LTS interneurons
To test whether the endocannabinoid 2-AG was involved in LTS-cell SSI, we prevented its biosynthesis by including in the whole-cell pipette either THL or O-3841, two inhibitors of DAGLs (Bisogno et al., 2003, 2006), the enzymes required to convert 1,2-diacylglycerol (1,2-DAG) into 2-AG. The two compounds are at least 160-fold selective for 2-AG over anandamide biosynthesis, and do not interact directly with CB1 receptors at the concentrations used to block DAGL (Bisogno et al., 2006). In the presence of either THL (1 μm) or O-3841 (3 μm), SSI-inducing stimuli failed to trigger significant long duration changes in either membrane potential or conductance in LTS interneurons (Figs. 2C–F, 3). Under vehicle control condition (intracellular DMSO 1 μl/ml) SSI-inducing action potential trains induced membrane potential hyperpolarizations of 6.8 ± 0.1 mV (Figs. 2A, 3A) (p < 0.001, n = 11; paired t test). In contrast, no change in membrane potential was observed in the posttrain equivalent period with THL and O-3841 in the intracellular solution (Figs. 2C,E, 3A) (THL: −1.0 ± 1.3 mV, n = 7, p > 0.5; O-3841: −1.5 ± 1.7 mV n = 9, p > 0.5). SSI-inducing stimuli elicited increases in normalized gm (Fig. 3B) (ratio of membrane conductance pre- and post-SSI of 1.6 ± 0.1; p < 0.02, paired t test; n = 6) comparable to those reported in previous experiments (Bacci et al., 2004). The increased conductance was blocked by intracellular THL (Fig. 3B) (normalized gm following SSI-inducing stimuli was 1.1 ± 0.04; p > 0.05, n = 8) or by O-3841 (normalized gm 1.3 ± 0.14; p > 0.05, n = 7). Normalized gm after the trains was significantly higher in control than in O-3841 and THL (p < 0.03).
PLCβ blockade prevents SSI in LTS interneurons
Diacylglycerols (DAGs) are DAGL substrates for 2-AG production (Piomelli, 2003; Di Marzo et al., 2005). A prominent pathway for DAG biosynthesis involves PLCβ, which converts the phospholipid phosphatidylinositol into 1,2 diacylglycerol (1,2 DAG). This process can be triggered by rises of [Ca2+]i, such as those occurring during sustained electrical activity. PLCβ activity provides substrates for DAGL during activity-dependent 2-AG production (Piomelli, 2003; Bisogno et al., 2005). To test whether 2-AG produced by PLC activity was involved in SSI, we blocked PLC using U-73122 (5 μm). Inclusion of the drug in the patch pipette (as in experiments involving THL or O-3841 depicted in Figs. 2, 3) was not feasible, because under these conditions (intracellular U-73122 perfusion) LTS interneurons were unstable and could not be recorded for longer than few minutes. Slices were therefore preincubated for at least 15 min with U-73122 in the extracellular solution and cells were then recorded in the continuous presence of the PLC blocker. Under these conditions, the aforementioned toxic effects were absent and recordings from LTS interneurons were stable. In the presence of U-73122, SSI was prevented in LTS interneurons (Fig. 4A). Overall, membrane potential measured 7 min after SSI-inducing trains was not significantly different from control pretrain periods (ΔVm = −1.8 ± 1.7 mV, p > 0.2; n = 5). Similarly, PLC blockade by U-73122 prevented membrane conductance changes normally associated with SSI (normalized gm after SSI-inducing spike trains was 1.0 ± 0.01; p > 0.05, n = 5). We repeated the same experiment in the presence of U-73343 (5 μm), an inactive analog of U-73122. In the presence of U-73343, LTS-cell SSI was similar to that found under control conditions (Fig. 4B). Overall, membrane potential hyperpolarization was −10.9 ± 2.5 mV after SSI-inducing trains (n = 5; p < 0.01). Moreover, normalized gm was 1.4 ± 0.02 after action potential trains (p < 0.05; n = 5), similar to the SSI induced increase in gm in control conditions (Fig. 3B). It is possible that DAGL and PLC inhibitors prevented SSI by blocking signaling events downstream from CB1R activation. We therefore applied 2-AG with a local perfusion pipette in the continuous presence of extracellular U-73122 and intracellular THL. Exogenous application of 2-AG resulted in a consistent hyperpolarization of Vm (ΔVm = −7.8 ± 0.1, p < 0.05, n = 5) (supplemental Fig. S3, available at www.jneurosci.org as supplemental material), ruling out the possibility that DAGL and PLC blockers affected processes downstream from CB1 receptor activation.
mGlu5-dependent activation of PLCβ induces a hyperpolarization in LTS interneurons, mediated by 2-AG
Activation of group I mGluRs results in PLCβ stimulation associated with endocannabinoid synthesis and modulation of synaptic transmission (Varma et al., 2001; Brown et al., 2003; Freund et al., 2003; Piomelli, 2003; Jung et al., 2005, 2007; Maejima et al., 2005; Chevaleyre et al., 2006). In particular, activation of the mGlu5 subtype of group I mGluRs results in selective 2-AG formation, with no significant change in anandamide production (Jung et al., 2005, 2007). We then reasoned that an mGlu5-dependent activation of PLCβ should produce 2-AG and thus mimic SSI in LTS interneurons. In the presence of the Na+ channel blocker TTX (0.5 μm), local perfusion of the selective mGlu5 agonist CHPG (1 mm) resulted in a prominent depolarization of LTS cells, consistent with the known activation of a cationic channel by group I mGluRs (Guérineau et al., 1995; Tempia et al., 1998; Kim et al., 2003). Upon CHPG washout, membrane potential persistently hyperpolarized, mimicking SSI (Fig. 5A,B) (Vm = −60.0 ± 2.2 vs −66.4 ± 2.0 mV, predrug vs 5 min after CHPG washout; p < 0.01; n = 5; Wilcoxon signed-rank test). Membrane conductance greatly increased during CHPG application (Fig. 5A), consistent with the opening of membrane ion channels with a depolarized equilibrium potential. During CHPG washout, membrane conductance transiently returned to predrug values before increasing during the persistent membrane potential hyperpolarization (Fig. 5B, right) (gm = 2.1 ± 0.1 nS pre-CHPG vs 2.6 ± 0.2 nS 5 min after CHPG washout; p < 0.02; n = 5). To test whether the long-lasting hyperpolarization following CHPG local perfusion was similar to SSI and thus endocannabinoid-mediated, we repeated the same experiments in the presence of the CB1 antagonist AM251 (2 μm). When AM251 was present, CHPG application produced the prominent depolarization but not the long-lasting hyperpolarization (Fig. 5C,D), indicating that CB1Rs were involved in the CHPG-dependent late hyperpolarization. Overall, membrane potential did not significantly hyperpolarize in LTS interneurons in the presence of AM251 (Vm = −62.0 ± 2.9 predrug vs −61.4 ± 3.6 mV. 5 min after CHPG washout; p > 0.1, n = 5). Moreover, the late membrane conductance increase occurring during CHPG washout was prevented by AM251 application (Fig. 5D, right) (gm = 2.0 ± 0.3 pre-CHPG vs 2.1 ± 0.3 nS 5 min after CHPG washout; p > 0.1, n = 5).
The involvement of PLCβ in this CHPG-mediated effect was confirmed, as the late hyperpolarization was prevented by U-73122 (Vm and gm were −58.1 ± 2.4 mV and 1.8 ± 0.3 nS, respectively pre-CHPG and −57.8 ± 2.4 mV and 2.2 ± 0.6 nS, 5 min after CHPG washout; p > 0.1 in both cases, n = 5) (Fig. 5E,F). Moreover, the late hyperpolarization was also blocked by the DAGL inhibitor THL (Vm and gm were = −56.9 ± 2.1 and 2.0 ± 0.4 nS, respectively pre-CHPG and −58.7 ± 2.5 mV and 2.3 ± 0.4 nS 5 min after CHPG washout; p > 0.1 in both cases, n = 6) (Fig. 5G,H). These data indicate that mGlu5 activation in LTS interneurons produced a PLCβ- and DAGL-dependent synthesis of 2-AG, resulting in a hyperpolarization that mimicked SSI.
Discussion
Slow self-inhibition (SSI) of LTS cortical interneurons is an endocannabinoid-dependent persistent and prominent change of somatodendritic excitability. We have previously shown that LTS interneurons in layer V of the neocortex include CCK-positive cells (Bacci et al., 2004), consistent with earlier reports (Kawaguchi and Kubota, 1997, 1998). This agrees with the known expression of CB1Rs in CCK-containing interneurons in both neocortex and hippocampus (Freund et al., 2003). However, LTS firing behavior is also a prominent feature of somatostatin (SST)-containing Martinotti cells (Cauli et al., 1997; Kawaguchi and Kondo, 2002; Goldberg et al., 2004; Ma et al., 2006). We show that the majority of LTS interneurons recorded here do indeed express SST. Recently, immunohistochemical analysis (Katona et al., 2006) and single-cell RT-PCR (Hill et al., 2007) revealed that CB1Rs are expressed by glutamatergic neurons and other subtypes of GABAergic cells. In particular, CB1 mRNA has been found in a significant percentage of SST-positive interneurons (Hill et al., 2007), in agreement with previous evidence indicating that a significant percentage of calbindin D28K-positive cortical interneurons—thus likely coexpressing SST (Cauli et al., 1997, 2000; Kawaguchi and Kubota, 1997; Hill et al., 2007)—express CB1 receptors (Marsicano and Lutz, 1999). In line with this evidence, we showed that activity-dependent slow self-inhibition occurs in the vast majority of LTS interneurons that we recorded (78%), including SST-positive cells, identified with post hoc immunocytochemistry. Accordingly, neocortical neurons showing an LTS firing behavior responded to exogenous applications of 2-AG with a prominent hyperpolarization (Bacci et al., 2004) (supplemental Fig. 3, available at www.jneurosci.org as supplemental material). These data indicate that in deep cortical layers CB1Rs are functionally expressed by a large percentage of SST-positive and virtually all CCK-expressing LTS interneurons.
Anandamide and 2-AG are the best characterized endogenous cannabinoids and, in particular, 2-AG is the most abundant endocannabinoid in the CNS, with a higher efficacy at CB1Rs than anandamide (Freund et al., 2003; Piomelli, 2003; Di Marzo et al., 2005). Here we show that the persistent hyperpolarization following repetitive firing of neocortical LTS-cells is prevented by blocking the biosynthesis of 2-AG. Production of 2-AG was specifically impaired by blocking two crucial enzymes involved in its biosynthesis. We first blocked DAGL using two different drugs. We used tetrahydrolipstatin (THL or orlistat), which is a potent blocker of DAGL and other lipases (Lee et al., 1995; Bisogno et al., 2003, 2006; Hashimotodani et al., 2008) with little or no activity on the enzyme catalyzing anandamide biosynthesis (Lee et al., 1995; Bisogno et al., 2003, 2006). In addition, we used a newly synthesized compound, O-3841, which was shown to be less potent than THL but much more specific for sn-1-DAG lipase (Bisogno et al., 2006). The experimental approach of including these two drugs in the whole-cell intracellular solution excludes the possibility that their effects of blocking SSI in LTS cells could be attributed to indirect actions of these molecules on other cells embedded in the network. Moreover, intracellular delivery of these DAGL inhibitors clearly indicates that 2-AG is produced by the same LTS neuron that underwent repetitive cycles of activity, confirming that SSI is mediated by an autocrine endocannabinoid action. Control experiments, performed in the presence of equivalent amounts of the drug solvent DMSO, rule out the possibility that SSI blockade could be induced by the drug vehicle perfused intracellularly.
The production of 2-AG in the somatodendritic compartment of LTS interneurons correlates with the expression of DAGL in dendrites of neurons in postembryonic developmental stages, as opposed to its axonal distribution during embryonic development (Bisogno et al., 2003; Yoshida et al., 2006). On the other hand, the 2-AG degrading enzyme monoacylglycerol lipase (MAGL) is localized mainly in presynaptic terminals, as are CB1 receptors (Dinh et al., 2002; Gulyas et al., 2004). This might in part explain the long-lasting nature of SSI, which is induced and maintained in the somatodendritic compartments lacking the enzyme responsible for breaking down 2-AG. This endocannabinoid would thus remain at higher concentrations and exert a prolonged interaction with CB1 receptors, as suggested by experiments in which late application of CB1 antagonist AM251 only partially reversed the hyperpolarization and membrane conductance changes induced by SSI stimuli (Bacci et al., 2004) (Fig. 1). On the other hand, elevated MAGL expression in presynaptic terminals might underlie the short-term dynamics of DSI (Alger, 2002), as suggested by experiments in which DSI duration was increased by blockade of MAGL (Makara et al., 2005; Szabo et al., 2006). Eventually, also in the absence of MAGL, 2-AG might be inactivated either via incorporation into phospholipids or by fatty acid amide hydrolase (FAAH) (Di Marzo et al., 1998), which is predominantly a postsynaptic enzyme (Gulyas et al., 2004), as opposed to presynaptic localization of MAGL. Furthermore, two other lipases, Abh6 and Abh12, have been recently identified in the brain and shown to recognize 2-AG as a substrate (Blankman et al., 2007), although their anatomical and cellular distribution in the brain is not known.
DAGL-dependent production of 2-AG relies on the availability of diacylglycerols, which can be produced by PLCβ activity. There is compelling evidence that 2-AG production in forebrain neurons depends more strongly on PLCβ and DAGL than other biosynthetic pathways (Stella et al., 1997; Freund et al., 2003; Piomelli, 2003; Jung et al., 2007), and 2-AG has been suggested to be the retrograde messenger involved in short- and long-term synaptic modulation (Melis et al., 2004; Makara et al., 2005; Safo and Regehr, 2005; Chevaleyre et al., 2006; Szabo et al., 2006; Hashimotodani et al., 2007, 2008). However, PLCβ involvement in endocannabinoid-mediated retrograde synaptic signaling is still unclear. Both pharmacological and genetic analyses strongly suggest PLC-dependent 2-AG production triggered by mGluR and/or muscarinic ACh receptor activation in short- and long-term synaptic plasticity (Kim et al., 2002; Hashimotodani et al., 2005; Maejima et al., 2005; Chevaleyre et al., 2006). In contrast, PLCβ involvement in briefer depolarization- and DAGL-dependent DSI/DSE is still controversial (Chevaleyre and Castillo, 2003; Edwards et al., 2006; Szabo et al., 2006; Hashimotodani et al., 2008).
We found that LTS-cell SSI depends on PLCβ-like activity. This was supported by two lines of evidence. First, SSI was prevented in the presence of U-73122, which is a known PLCβ inhibitor, widely used in biochemical and physiological studies to prevent PLCβ activity. This drug was recently reported to have undesired unspecific effects (Hashimotodani et al., 2008). However, the presence of robust SSIs induced in LTS interneurons in the presence of U-73122's inactive analog U-73343 suggests that SSI blockade by U-73122 is likely due to its known effects on PLC, even though we cannot completely exclude unspecific effects by the drug. However, LTS cells consistently hyperpolarized when locally perfused with 2-AG in the presence of U-73122 (as well as THL), indicating that the PLC blocker does not affect CB1-sensitive K+ channels (Sickmann et al., 2008).
Second, group I mGluR-dependent PLCβ activation produced a CB1-dependent hyperpolarization mimicking SSI in LTS cells. This mGlu5-dependent hyperpolarization resulted from PLCβ activation, as it was prevented by U-73122. Group I mGluR-dependent PLCβ activation results in endocannabinoid synthesis (Maejima et al., 2001; Varma et al., 2001; Alger, 2002; Safo and Regehr, 2005; Chevaleyre et al., 2006), and, in particular, the mGlu5 subtype of group I mGluRs was shown to selectively induce 2-AG synthesis in rat corticostriatal and hippocampal slice cultures (Jung et al., 2005). Accordingly, the persistent hyperpolarization and conductance increase triggered in LTS interneurons by selective mGlu5 activation and prevented by the CB1 antagonist AM251, was mediated by 2-AG, as it was prevented when DAGL activity was pharmacologically impaired. It will be interesting to investigate whether glutamate released during sustained network activities can activate mGluRs and thus elicit the endocannabinoid-dependent SSI in LTS interneurons. PLCβ activation by direct Ca2+ increases, such as those triggered by SSI-inducing action potential trains is still controversial (Chevaleyre and Castillo, 2003; Edwards et al., 2006; Szabo et al., 2006; Hashimotodani et al., 2008). PLC activation requires a certain level of intracellular Ca2+ (Rebecchi and Pentyala, 2000), and interestingly, isoforms of PLC that are highly sensitive to Ca2+ and are expressed in cortex and hippocampus have recently been identified (PLCη1 and PLCη2) (Hwang et al., 2005; Nakahara et al., 2005). During cortical network activity, a synergistic action between mGluR activation and action potential firing could exist, with a resulting modulation of LTS-cell SSI, similar to that shown in cerebellar DSE (Brenowitz and Regehr, 2005).
Altogether, our results suggest that during repetitive action potential firing, LTS interneurons activate PLCβ, which provides DAGL with its natural substrates for 2-AG production. This can in turn activate CB1 receptors in the same cells and trigger long-lasting self-inhibition through a persistent hyperpolarization. In our control experiments LTS interneurons consistently generated SSI (supplemental Fig. 1, available at www.jneurosci.org as supplemental material) that was prevented by DAGL and PLC blockers, although. SSI could not be elicited in all SST-positive LTS cells.
It is possible that anandamide is also involved in SSI, but we could not directly test its role in SSI induction, because to date there is no selective pharmacological tool available to impair its biosynthesis. However, even if produced by repetitive firing in LTS cells, anandamide might not be efficient in inducing persistent SSI, as the enzyme specific for its degradation, the fatty acid amide hydrolase (FAAH) is expressed in somata and dendrites of cortical neurons (Romero et al., 2002; Egertová et al., 2003; Piomelli, 2003). This suggests that even if anandamide were produced by repetitive firing, it would be quickly degraded. Moreover, recent evidence indicates that anandamide can, under certain conditions, downregulate 2-AG biosynthesis (Maccarrone et al., 2008), arguing against a possible synergistic effect of the two endocannabinoids. Finally, if anandamide were involved in LTS-cell SSI, a residual hyperpolarization should have been present when 2-AG biosynthesis was blocked by PLC and DAGL inhibitors, at least immediately after SSI-inducing trains.
In the neocortex and hippocampus, interneurons are important players in cortical circuit activity. Some interneurons such as basket cells are responsible for induction and maintenance of various cortical oscillations, by providing feedback inhibition onto glutamatergic pyramidal cells (Freund, 2003; Whittington and Traub, 2003; Buzsáki et al., 2004). In contrast, other GABAergic interneurons target pyramidal cell dendrites and might be thus responsible for filtering excitation onto pyramidal neurons (Pouille and Scanziani, 2001; Xiang et al., 2002; Pouille and Scanziani, 2004). Neocortical LTS interneurons belong to this latter class of cells (Xiang et al., 2002; Bacci et al., 2005) and their self-induced inhibition by 2-AG might provide a persistent tuning of information processing along the dendritic axis of pyramidal cells.
Footnotes
-
This work was supported by the Giovanni Armenise-Harvard Foundation Career Development Award (A.B.); European Commission Marie Curie International Reintegration Grant (A.B.); National Alliance for Research on Schizophrenia and Depression Young Investigator Award (A.B.); Ministero dell'Università e della Ricerca (Fondo per gli Investimenti della Ricerca di Base) and Italian Institute of Technology (A.B.); National Institutes of Health Grant NS39579 from the National Institute of Neurological Disorders and Stroke (D.A.P., J.R.H.); and the Morris and Pimley research funds (D.A.P.). We thank Drs. Raj Razdan (Organix), and Billy Martin (Department of Pharmacology and Toxicology, Virginia Commonwealth University) for the gift of O-3841.
- Correspondence should be addressed to Dr. Alberto Bacci, European Brain Research Institute, Via del Fosso di Fiorano 64, 00143 Roma, Italy. a.bacci{at}ebri.it